North Haven, CT, United States of America

M Diana Danca

This inventor holds 1 USPTO granted patent. Top assignee: Cgi Pharmaceuticals, Inc.. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: M Diana Danca. Retrieved from https://idiyas.com/inventor/m-diana-danca

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 41(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: M Diana Danca: Innovator in Kinase Modulation

Introduction

M Diana Danca is a notable inventor based in North Haven, CT (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the modulation of kinase activity. His innovative work has the potential to impact the treatment of various diseases and disorders.

Latest Patents

M Diana Danca holds a patent for "Certain substituted imidazo[1,2-a]pyrazines, as modulators of kinase activity." This patent includes compounds that are designed to modulate EphB4 kinase activity, which is crucial for treating patients suffering from diseases responsive to this modulation. The patent outlines pharmaceutical compositions containing these compounds, along with methods for treating patients and determining the presence of angiogenic kinases in samples.

Career Highlights

Danca is currently associated with Cgi Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work focuses on creating effective therapeutic agents that can significantly improve patient outcomes.

Collaborations

Some of his notable coworkers include James William Darrow and Douglas A Pippin. Their collaborative efforts contribute to the innovative environment at Cgi Pharmaceuticals, Inc.

Conclusion

M Diana Danca's contributions to kinase modulation represent a significant advancement in pharmaceutical research. His innovative patents and ongoing work at Cgi Pharmaceuticals, Inc. highlight his commitment to improving healthcare through scientific innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…